Back to search

United States· US:46122-603_0d291a5f-b635-380c-e063-6394a90a0310

GNP EyeDrops Maximum Redness Relief

A enemas product containing glycerin, naphazoline hcl, registered in United States by AmerisourceBergen. The same ATC class is registered in 2 of our 19 countries.

ATC A06AGUS label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedGNP EyeDrops Maximum Redness ReliefATCA06AGREGISTER NO.US:46122-603_0d291a5f…PACKS LISTED1CHECKEDJune 3, 2026

Where it is registered

Glycerin, naphazoline hcl is registered in 2 of 19 countries.

Countries holding a registration under ATC A06AG (enemas), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 2 of them publish a price we can compare per daily dose

Glycerin, naphazoline hcl · ATC A06AG

2 / 19 countries

  • Belgiumprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
glycerin, naphazoline HCl
Manufacturer
AmerisourceBergen
Country
United States (US)
ATC code
A06AG
ATC class
Enemas
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
June 3, 2026

Packs & prices · 1

  • ndc11
    4612260305
    1 BOTTLE, DROPPER in 1 CARTON (46122-603-05) / 15 mL in 1 BOTTLE, DROPPER

Regulatory notes

UNII (FDA substance ID)
PDC6A3C0OX
GLYCERIN
RxCUI 4910
DailyMed SPL labels
1 version tracked

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cbf79e9c-0ef9-4a61-b10a-efa5fff7e8c7
GET /v1/drugs/cbf79e9c-0ef9-4a61-b10a-efa5fff7e8c7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "PDC6A3C0OX",
    "rxcui": "4910",
    "inchikey": "PEDCQBHIVMGVHV-UHFFFAOYSA-N",
    "display_name": "GLYCERIN",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "OPHTHALMIC",
  "spl_meta": {
    "0bcc55bf-9654-120b-e063-6394a90a59d1": {
      "match": "brand_token",
      "title": "GNP VAPOR STEAM CAMPHOR (SYNTHETIC) (CAMPHOR (SYNTHETIC)) LIQUID [AMERISOURCEBERGEN]",
      "spl_version": "4",
      "published_date": "2026-01-28"
    }
  },
  "productid": "46122-603_0d291a5f-b635-380c-e063-6394a90a0310",
  "productndc": "46122-603",
  "dosage_form": "SOLUTION",
  "dea_schedule": null,
  "product_type": "HUMAN OTC DRUG",
  "substance_name": "GLYCERIN; NAPHAZOLINE HYDROCHLORIDE",
  "proprietary_name": "GNP EyeDrops Maximum Redness Relief",
  "active_ingred_unit": "g/100mL; g/100mL",
  "application_number": "M018",
  "marketing_category": "OTC MONOGRAPH DRUG",
  "nonproprietary_name": "glycerin, naphazoline HCl",
  "start_marketing_date": "20190905",
  "active_numerator_strength": ".5; .03"
}

See everything about glycerin, naphazoline hcl.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.